Assessing cardiovascular disease: looking beyond cholesterol : Current Opinion in Endocrinology, Diabetes and Obesity

the United States, or the Qrisk3 in the UK. A study in JAMA in 2022 suggested that ‘the absolute benefits of statins are modest and may not be strongly mediated through the degree of LDL reduction’. Perhaps it is time to look beyond cholesterol...